This Biotech Company Is Giving $25 Million In Resources To Projects That Combat Coronavirus $4.2 billion synthetic biology powerhouse Ginkgo Bioworks is giving $25 million worth of resources in their $400 million R&D facility to public and private teams working to cure, prevent and treat the novel coronavirus.